Medicare Enrolled
Dr. Andres Nisimblat, M.D.
Family Medicine · Corpus Christi, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Nisimblat from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nisimblat? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nisimblat
Dr. Andres Nisimblat is a family medicine in Corpus Christi, TX, with 19 years in practice. Based on federal Medicare data, Dr. Nisimblat performed 15,033 Medicare services across 10,173 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nisimblat received a total of $9,668 from 44 pharmaceutical and/or device companies across 652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nisimblat is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 1% volume in TX$ $9,668 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,033
Medicare services
Top 1% in TX for family medicine
10,173
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~791 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 1,338 | $8 | $10 |
| Comprehensive metabolic blood panel | 1,267 | $10 | $16 |
| Complete blood count (CBC) with differential | 1,026 | $8 | $15 |
| Lipid panel (cholesterol and triglycerides) | 955 | $13 | $20 |
| Lactate dehydrogenase (enzyme) level | 794 | $6 | $10 |
| Glutamyltransferase (liver enzyme) level | 783 | $7 | $15 |
| Thyroid stimulating hormone (TSH) test | 715 | $16 | $30 |
| Manual urinalysis test with examination using microscope, non-automated | 712 | $4 | $5 |
| Hemoglobin A1c test (diabetes monitoring) | 640 | $9 | $15 |
| Free thyroxine (T4) test | 619 | $9 | $13 |
| Thyroid hormone, t3 measurement, total | 540 | $14 | $21 |
| Office visit, established patient (20-29 min) | 499 | $60 | $150 |
| Office visit, established patient (30-39 min) | 499 | $86 | $200 |
| Creatinine test (kidney function) | 374 | $5 | $8 |
| Office visit, established patient, complex (40-54 min) | 373 | $107 | $250 |
| Annual wellness visit, follow-up | 360 | $126 | $215 |
| Urine microalbumin test (kidney screening) | 342 | $6 | $8 |
| Apolipoprotein level | 327 | $21 | $21 |
| Flu vaccine administration | 240 | $29 | $40 |
| Flu vaccine, high-dose | 232 | $71 | $75 |
| Annual alcohol misuse screening, 5 to 15 minutes | 193 | $18 | $40 |
| Vitamin B-12 level test | 183 | $15 | $25 |
| Vitamin D level test | 164 | $29 | $42 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 141 | $25 | $40 |
| Prostate cancer screening; prostate specific antigen test (psa) | 134 | $19 | $27 |
| Iron level test | 98 | $6 | $9 |
| Insulin measurement, total | 97 | $11 | $17 |
| Iron binding capacity test | 93 | $9 | $13 |
| Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | 89 | $139 | $153 |
| Ferritin level test (iron stores) | 87 | $13 | $25 |
| Drug injection, under skin or into muscle | 86 | $9 | $30 |
| Magnesium level test | 77 | $7 | $10 |
| PSA test (prostate cancer screening) | 77 | $18 | $27 |
| Uric acid level test | 70 | $4 | $7 |
| Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | 68 | $18 | $50 |
| C-reactive protein test (inflammation marker) | 57 | $5 | $8 |
| Basic metabolic blood panel | 55 | $8 | $12 |
| Sed rate test (inflammation marker) | 55 | $3 | $4 |
| Pneumonia vaccine administration | 55 | $30 | $40 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 54 | $282 | $315 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 41 | $27 | $110 |
| Natriuretic peptide (heart and blood vessel protein) level | 39 | $38 | $50 |
| Total protein level, urine | 33 | $3 | $20 |
| Creatine kinase (cardiac enzyme) level, total | 32 | $6 | $10 |
| Kidney function blood test panel | 30 | $8 | $15 |
| Phosphate level test | 30 | $5 | $30 |
| Parathyroid hormone level test | 26 | $40 | $55 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 25 | $162 | $200 |
| Testosterone (hormone) level, total | 24 | $25 | $40 |
| Electrocardiogram (EKG), 12-lead | 20 | $8 | $65 |
| Transitional care management services for problem of high complexity | 20 | $216 | $450 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 19 | $41 | $120 |
| Folic acid level test | 18 | $14 | $25 |
| Rheumatoid factor level | 18 | $6 | $8 |
| Measure of severe acute respiratory syndrome coronavirus 2 (covid-19) antibody | 18 | $41 | $45 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 17 | $14 | $25 |
| Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | 15 | $16 | $17 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $162 | $243 |
| Lipase (fat enzyme) level | 14 | $7 | $15 |
| Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 11 | $25 | $40 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$9,668
Total received (2018-2024)
Avg $1,381/year across 7 years
Top 5% in TX for family medicine
44
Companies
652
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,668 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,962
2023$2,234
2022$1,501
2021$994
2020$358
2019$1,203
2018$1,415
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,826
Lilly USA, LLC
$1,253
Amgen Inc.
$821
GlaxoSmithKline, LLC.
$770
Kowa Pharmaceuticals America, Inc.
$704
PFIZER INC.
$584
Amarin Pharma Inc.
$520
AstraZeneca Pharmaceuticals LP
$492
Merck Sharp & Dohme LLC
$310
Dexcom, Inc.
$276
ABBVIE INC.
$242
SANOFI PASTEUR INC.
$186
Esperion Therapeutics, Inc.
$174
Bayer Healthcare Pharmaceuticals Inc.
$132
SANOFI-AVENTIS U.S. LLC
$130
Merck Sharp & Dohme Corporation
$122
Exact Sciences Corporation
$120
Boehringer Ingelheim Pharmaceuticals, Inc.
$111
Novartis Pharmaceuticals Corporation
$89
Sanofi Pasteur Inc.
$61
SHIELD THERAPEUTICS INC
$59
DEXCOM, INC.
$58
Radius Health, Inc.
$46
Takeda Pharmaceuticals U.S.A., Inc.
$46
Janssen Pharmaceuticals, Inc
$42
ARBOR PHARMACEUTICALS, INC.
$41
Genentech USA, Inc.
$41
Bayer HealthCare Pharmaceuticals Inc.
$41
MannKind Corporation
$38
IDORSIA PHARMACEUTICALS US INC
$36
OPTOS, INC.
$33
IBSA Pharma Inc.
$29
Teva Pharmaceuticals USA, Inc.
$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$27
VistaPharm, Inc.
$23
Phadia US Inc.
$22
Phathom Pharmaceuticals, Inc.
$22
Seqirus USA Inc
$19
NESTLE HEALTHCARE NUTRITION INC.
$19
Sumitomo Pharma America, Inc.
$18
Currax Pharmaceuticals LLC
$17
Regeneron Healthcare Solutions, Inc.
$14
Shield Therapeutics Inc
$14
Biohaven Pharmaceutical Holding Company Ltd.
$12
Top 3 companies account for 40.3% of total payments
Associated products mentioned in payments ›
ACCRUFER · ADACEL · AFREZZA · AJOVY · AREXVY · Aimovig · BASAGLAR · BELSOMRA · BEXSERO · BREZTRI · CAPVAXIVE · CHANTIX · COMIRNATY · CONTRAVE · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ELIQUIS · ENTRESTO · EVENITY · Edarbi · FARXIGA · FLUBLOK QUADRIVALENT · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · GEMTESA · Horizant · ImmunoCAP · JANUVIA · Kerendia · LEQVIO · LIVALO · LYRICA · Livalo · MOUNJARO · Monaco · NEXLETOL · NURTEC ODT · Otezla · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRALUENT ALIROCUMAB INJECTION · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QULIPTA · QUVIVIQ · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · Saxenda · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · VOQUEZNA · Vascepa · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in TX.
Equivalent to $64 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
194
Per 100K population
55.0
County median income
$66,021
Nearest hospital
CORPUS CHRISTI MEDICAL CENTER,THE
4.9 mi
4.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Nisimblat is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and high industry engagement (low-engagement, top 5%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Nisimblat experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Nisimblat performed 1,338 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nisimblat receive payments from pharmaceutical companies?
Yes. Dr. Nisimblat received a total of $9,668 from 44 companies across 652 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nisimblat's costs compare to other family medicines in Corpus Christi?
Dr. Nisimblat's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nisimblat) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Corpus Christi
Browse family medicines in Corpus Christi ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology